APPLICATIONS PUBLISHED 26 JANUARY 2005
Published: 1-Feb-2006
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Use of haem oxygenase-1 and products of haem degradation
Beth Israel Deaconess Medical Centre 1499186*
Immunostimulatory G,U-containing oligoribonucleotides
Coley Pharmaceutical 1499187*
Method of reducing calcified arterial plaque build-up and cellular malfunction and for balancing ionic calcium
Gusty Winds Corp 1499189*
Methods for treating liver disease and liver damage with growth hormone and FOXM1B
The Board of Trustees of the University of Illinois 1496190*
Regulated attenuation of live vaccines to enhance cross protective immunogenicity
Washington University in St Louis 1499191*
Biologically active compounds for the modification of bodily odours
Max-Planck-Gesellschaft zur Foerderung des Wissenschaften 1499284*
Volume efficient controlled release dosage form
Alza Corp 1499289*
Method and dosage forms for controlled delivery of oxycodone
Alza Corp 1499291*
In vivo imaging of apoptosis
The General Hospital Corp 1499292*
Topical application of alpha-DFMO and anti-inflammatory drug for the treatment of actinic keratoses
Topical Technologies 1499293*
Transport system in biological systems
Biotesys 1499294*
Sustained release metoprolol formulations
Penwest Pharmaceuticals 1499295*
Formulation of fine particles using liquified or dense gases
Eiffel Technologies 1499297*
Pharmaceutical formulation comprising atorvastatin calcium
Lek Pharmaceutical and Chemical 1499297*
Oral administration form for difficulty soluble basic active ingredients which are applied orally
Boehringer Ingelheim Pharma 1499298*
Microparticle pharmaceutical compsns for intratumoral delivery
Teva Pharmaceutical Industries; West Pharmaceutical Services Drug Delivery & Clinical Research Centre 1499299*
Pharmaceutical formulations with improved bioavailability
Shire Laboratories; Shojaei, Amir; Flanner, Henry; Ibrahim, Scott 1499300*
Method of stabilising bupropion hydrochloride tablets
Ranbaxy Laboratories 1499301*
Multi-phase, multi-compartment capsular system
Miller, Fred 1499303*
Liquid compositions for soft sustained-release capsules and method for production thereof
Paris, Laurence 1499304*
Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
Pfizer Japan 1499305*
Bicyclic amides
Merck 1499306*
Tri-substituted heteroaryls and methods of making and using the same
Biogen 1499308*
Prevention and treatment of functional somatic disorders, including stress-related disorders
Cypress Bioscience 1499309*
Carvedilol monocitrate monohydrate receptor modulators
SB Pharmco Puerto Rico 1499310*
Substituted benzazoles and use thereof as RAF kinase inhibitors
Chiron Corp 1499311*
The use of hydroxypyridone-derivatives in wound healing
Aventis Pharma Deutschland 1499312*
Heterocyclic derivatives as opioid receptor modulators
Janssen Pharmaceutica 1499313*
N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
Procter & Gamble 1499314*
Combination of cyclooxygenase-2 inhibitors and thalidomide for the treatment of neoplasia
Pharmacia 1499315*
(1-4-piperidinyl)benimidazole derivatives useful as histamine H3 antagonists
Schering 1499316*
Treatment of diabetes and diabetic complications with NHE-1 inhibitors
Pfizer 1499317*
Peptide deformylase activated prodrugs
Celmed Oncology 1499318*
Bicyclo 4.4.0 antiviral derivatives
Bristol-Myers Squibb 1499319*
Novel compounds
SmithKline Beecham 1499320*
Methods for increasing the therapeutic response to electroconvulsive therapy
Corcept Therapeutics 1499321*
Use of conjugated estrogens in combination with trimegestone in HRT.
Wyeth 1499322*
Treatment of hypertension in women receiving hormone replacement therapy
Schering 1499323*
Method for treating and preventing hyperparathyroidism
Bone Care International 1499324*
Methods and compositions for inhibition of irritation by disaccharide and metal ions
Misamitsu Pharmaceuticals 1499325*
Oxolide antibacterials
Abbott Laboratories 1499326*
Beta -amyloid peptide-binding proteins and polynucleotides encoding the same
Wyeth 1499327*
Methods of treating necrotising enterocolitis
University of Pittsburgh of the Commonwealth System of Higher Education 1499328*
Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass
Protexeon 1499329*
Arsenic therapy for APLS-type autoimmune lympho-proliferative syndrome in mice and humans
Centre National de la Recherche Scientifique (CNRS) 1499330*
Salt solution for colon cleansing
Braintree Laboratories 1499331*
Compositions and methods for treating cancer with an oncolytic viral agent
Hadasit Medical Research Services & Development Co. 1499332*
Methods of treating ileus
University of Pittsburgh of the Commonwealth System of Higher Education; Yale University 1499333*
Use of compositions containing petasites for treating diseases
Weber & Weber 1499334*
Chimeric hybrid analgesics
Kream, Richard M 1499335*
Protease inhibitors
Trustees of Tuft College 1499336*
Immunotherapeutic and immunoprophylactic reagents
Monash University 1499337*
7-hydroxy-16alpha-fluoro-5-androsten-17-ones and 7-hydroxy-16alpha-fluoro-5-androstan-17-ones and derivatives thereof
Schwartz, Arthur 1499338*
Anti-inflammatory and wound healing effects of lymphoid thymosin beta 4
Yale University; King's College London 1499339*
Proteins involved in the regulation of energy homeostasis
DeveloGen Aktiengesellschaft fuer entwicklungsbiologische Forschung 1499340*
Methods of inhibiting and treating bacterial biofilms by metal chelators
The University of Iowa Research Foundation 1499341*
Therapeutic composition for treatment of cancer by arginine depletion
Cancer Treatments International 1499342*
A method of modulating cellular activity
Medvet Science 1499343*
